PHAT · Phathom Pharmaceuticals, Inc.

$8.90 -2.74 (-23.54%) Earnings today

Market Cap

$928.36M

80.90M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-07-30	2026-06-30
8-K	2026-07-30	—
Investor Event Transcript	2026-06-30	—
Investor Event Transcript	2026-06-30	—
Investor Event Transcript	2026-06-30	—
8-K	2026-06-23	—
8-K	2026-05-21	2026-05-19
10-Q	2026-04-30	2026-03-31
8-K	2026-04-30	—
DEF 14A	2026-04-07	2026-05-19
8-K	2026-02-26	—
10-K	2026-02-26	2025-12-31
8-K	2026-01-08	2026-01-07
8-K	2026-01-07	—
8-K	2025-11-04	—
8-K	2025-10-30	—
10-Q	2025-10-30	2025-09-30
8-K	2025-10-27	2025-10-25
8-K	2025-10-06	2025-10-02
8-K	2025-08-07	—
10-Q	2025-08-07	2025-06-30
8-K	2025-06-16	—
8-K	2025-06-09	2025-06-03
8-K	2025-06-06	—
10-Q	2025-05-01	2025-03-31
8-K	2025-05-01	—
DEF 14A	2025-04-23	2025-06-03
8-K	2025-04-16	2025-04-11
8-K	2025-04-01	2025-03-31
8-K	2025-03-06	—
10-K	2025-03-06	2024-12-31
8-K	2024-12-11	—
10-Q	2024-11-07	2024-09-30
8-K	2024-11-07	—
8-K	2024-08-19	—
10-Q	2024-08-08	2024-06-30
8-K	2024-08-08	—
8-K	2024-07-18	—
10-K/A	2024-06-14	2023-12-31
10-Q/A	2024-06-14	2024-03-31
8-K	2024-05-24	2024-05-23
10-Q	2024-05-09	2024-03-31
8-K	2024-05-09	—
DEF 14A	2024-04-12	2024-05-23
10-K	2024-03-07	2023-12-31
8-K	2024-03-07	—
8-K	2024-02-13	—
8-K	2023-12-15	2023-12-13
8-K	2023-12-14	—
8-K	2023-12-06	—

Showing 1–50 of 135 filings

Key facts CIK 1783183 CUSIP 71722W107 13F (30d) 22 filings 22 filers Visit website Investor relations